Last updated on March 2019

Prevention of Episodic Migraine: Long-Term, Randomized, Open-Label Study to Evaluate the Safety and Tolerability of Oral Atogepant

Other Details:

You may be able to use currently prescribed migraine medication as backup treatment. Study related medical care and medical evaluations, physical exams, lab work and all study-related visits are provided at no cost to those who qualify for the study.

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.